Previous month:
November 2021
Next month:
January 2022

December 2021

Walmart improperly disposing of hazardous waste in California, lawsuit charges

Walmart is being charged with illegal disposal of hazardous waste by the California Attorney General’s Office and 12 district attorneys. For six years, Walmart violated the state's environmental laws by disposing of hazardous waste products at local landfills that aren’t equipped or authorized to receive this waste. Read more →

Decorative holiday mailboxes are being recalled by Target due to laceration hazards

Target is recalling about 174,300 letters to Santa decorative mailboxes. The mail slot on the mailbox can be sharp, posing a laceration hazard. Target has received nine reports of sharp mail slot openings and seven incidents of lacerations with three requiring medical attention. Read more →

Get your holiday packages mailed: The USPS deadline for retail ground in the Lower 48 is Dec. 15

If you’re shipping holiday cards and gifts for Christmas, Dec. 25, or Kwanzaa, Dec. 26–Jan. 1, or other holiday traditions, it’s a time to make a plan to get your packages mailed. The deadline for mailing packages through the U.S. Postal Service to arrive by Dec. 25 is tomorrow, Dec. 15. Read more →

Wireless earphones are being recalled by E-filliate due to burn and fire hazards

E-filliate is recalling about 301,800 wireless earphones that can overheat while charging or in use, posing burn and fire hazards. E-filliate has received 61 reports of the earphones overheating during charging or use, including five reports of fire and four reports of minor burn injuries. Read more →

Keep an eye on your financial institution because regulator found errors in examination of consumer transactions

In its role to check on financial institutions, the Consumer Financial Protection Bureau found that some violated federal law in the first half of 2021. “Today’s report reveals that irresponsible or mismanaged firms harmed Americans during the COVID-19 pandemic," said CFPB Director Rohit Chopra. Read more →

Vyera Pharmaceuticals to pay $40 million for raising price on life-saving drug more than 4,000%

Vyera Pharmaceuticals and a former CEO, Kevin Mulleady, entered into an agreement Tuesday with the New York Attorney General’s Office to end anticompetitive behavior in the pricing of a drug to treat toxoplasmosis. The agreement also requires the company to pay up to $40 million and bans Mulleady from the pharmaceutical industry for seven years. Read more →